KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Xenon Pharmaceuticals (XENE) Leases (2019 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Leases for 7 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Leases fell 16.54% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, down 16.54% year-over-year, with the annual reading at $6.6 million for FY2025, 16.54% down from the prior year.
  • Leases for Q4 2025 was $6.6 million at Xenon Pharmaceuticals, down from $7.0 million in the prior quarter.
  • The five-year high for Leases was $10.4 million in Q4 2022, with the low at $3.0 million in Q3 2021.
  • Average Leases over 5 years is $7.6 million, with a median of $7.9 million recorded in 2022.
  • The sharpest move saw Leases skyrocketed 285.34% in 2021, then fell 16.54% in 2025.
  • Over 5 years, Leases stood at $8.1 million in 2021, then increased by 29.17% to $10.4 million in 2022, then decreased by 11.66% to $9.2 million in 2023, then dropped by 13.64% to $7.9 million in 2024, then fell by 16.54% to $6.6 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $6.6 million, $7.0 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.